EU backs J&J booster; GSK/Sanofi shot delayed

EU regulators on Wednesday recommended Johnson & Johnson's shot for use as a booster dose. However, Sanofi and GlaxoSmithKline said they expect data from late-stage clinical trials of its booster dose of their COVID-19 vaccine candidate in the first quarter, instead of this year, another delay for the potential shot. #COVID19 #Omicron #Johnson&Johnson #GSK #Sanofi #News #Reuters Subscribe: http://smarturl.it/reuterssubscribe Reuters brings you the latest business, finance and breaking news video from around the globe. Our reputation for accuracy and impartiality is unparalleled. Get the latest news on: http://reuters.com/ Follow Reuters on Facebook:   / reuters   Follow Reuters on Twitter:   / reuters   Follow Reuters on Instagram: https://www.instagram.com/reuters/?hl=en